In the meantime, Prostate Cancer Research's report says, screening 45-69-year-olds at high risk - black men and those with a ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments ...

In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

In a study of US veterans, the authors say many would benefit from conservative management and active surveillance over ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Thumbs down for Roundup. Shocking research has revealed that more than a dozen chemicals used in popular weed killers like ...

“The MMAI risk classifier is a more precise and accurate prognosticator of metastasis than NCCN risk groups,” Dr Tward’s team wrote. “This approach aims to prevent both overtreatment and ...

Doctors are debating whether low-risk prostate cancers should no longer be called cancer, with a group of international experts suggesting many cases are “a normal aspect of ageing”.

Scientists uncover functionality of a genetic variant in the prostate specific antigen (PSA) gene to improve the current diagnostic test to help distinguish aggressive from non-aggressive prostate ...

When prostate cancer cells burst as a result of menadione treatment, there is no risk of metastasis ... However, the study ...